MIGDEN, M.; GUMINSKI, A.; GUTZMER, R.; LOQUAI, C.; SQUITTIERI, N.; FOLEY, P. . Hematology laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s180, 2023. DOI: 10.25251/skin.7.supp.180. Disponível em: https://jofskin.org/index.php/skin/article/view/2010. Acesso em: 3 jul. 2024.